ScreenerHero

BIOPOR BioPorto A/S

CPH · DK · Healthcare · Diagnostics & Research · bioporto.com
1.080DKK+2.37%Mkt Cap: 77.88M $P/E: —

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and …

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$242.77BUSDP/E 35.3
DHR
Danaher Corporation
$151.57BUSDP/E 38.4
NTRA
Natera, Inc.
$57.75BUSD
LONN
Lonza Group AG
$45.93BUSDP/E 38.2
A
Agilent Technologies, Inc.
$47.74BUSDP/E 33.4
WAT
Waters Corporation
$42.85BUSDP/E 110.5
IQV
IQVIA Holdings Inc.
$42.79BUSDP/E 32.3
ILMN
Illumina, Inc.
$41.30BUSDP/E 51.0
IDXX
IDEXX Laboratories, Inc.
$40.66BUSDP/E 36.2
MTD
Mettler-Toledo International Inc.
$30.72BUSDP/E 34.6
LH
Labcorp Holdings Inc.
$25.28BUSDP/E 25.8
DGX
Quest Diagnostics Incorporated
$25.21BUSDP/E 24.2
GH
Guardant Health, Inc.
$22.91BUSD
RVTY
Revvity, Inc.
$17.11BUSDP/E 73.3
MEDP
Medpace Holdings, Inc.
$16.83BUSDP/E 35.4
ERF
Eurofins Scientific SE
$14.16BUSDP/E 26.4
CRL
Charles River Laboratories International, Inc.
$14.56BUSD
ICLR
ICON Public Limited Company
$12.48BUSDP/E 170.2
BIM
bioMérieux S.A.
$10.27BUSDP/E 20.5
QGEN
Qiagen N.V.
$9.43BUSDP/E 23.2

Key Statistics

Company
Market Cap77.88M USD
Enterprise Value67.89M USD
Revenue (TTM)5.59M USD
Gross Profit4.43M USD
Net Income (TTM)-11.96M USD
Revenue/Share0.07 DKK
Last Price1.080 DKK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees44
CountryDK
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-18.00
PEG—
EV/EBITDA-35.78
EV/Revenue12.15
P/S13.94
P/B6.51
EPS (TTM)-0.01
EPS (Forward)-0.06
52W Range
0.839045% of range1.380
52W High1.380 DKK
52W Low0.8390 DKK
Profitability
Gross Margin75.44%
Oper. Margin504.07%
EBITDA Margin-33.95%
Profit Margin-203.83%
ROE-130.33%
ROA-88.13%
Growth
Revenue Growth-34.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.22M USD
CapEx (TTM)—
FCF Margin-8.90%
FCF Yield-0.64%
Net Debt-9.99M USD
Net Debt/EBITDA5.27
Balance Sheet
Debt/Equity0.12
Current Ratio4.09
Quick Ratio3.72
Book Value/Sh0.17 DKK
Cash/Share0.15 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 DKK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.750 DKK
Upside (mean)+62.0%
Target Range1.750 DKK – 1.750 DKK
# Analysts1
Ownership
Shares Out.495.10M
Float458.86M
Insiders29.80%
Institutions6.28%
Technical
SMA 501.166 (-7.4%)
SMA 2001.078 (+0.2%)
Beta1.38
S&P 52W Chg14.58%
Avg Vol (30d)190.99K
Avg Vol (10d)181.43K
Technical Indicators
RSI (14)42.7
MACD-0.0280
MACD Signal-0.0253
MACD Hist.-0.0027
BB Upper1.188 DKK
BB Middle1.109 DKK
BB Lower1.031 DKK
BB Width14.17%
ATR (14)0.0419 DKK
Vol Ratio (20d)2.69x